-
1Conference
المؤلفون: Qun Li (222962), Xiaoyan Zhang (50085), Jiao Feng (1463692), Dezhi Cheng (3916607), Lin Cai (104109), Zhang’an Dai (10583348), Shuyu Zhao (4453504), Jianmin Li (505211), Jingjing Huang (170112), Yu Fang (219603), Honglin Zhu (169482), Danhua Wang (504538), Sizhen Wang (10104212), Tonghui Ma (549091), Xianghe Lu (10583351)
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, next-generation sequencing, undifferential thyroid cancer, TERT promoter mutation, RET fusion, anlotinib, tumor origin
-
2
المؤلفون: Yibei Dai (5049215), Yiyun Wang (4716498), Ying Cao (170160), Pan Yu (522583), Lingyu Zhang (2180486), Zhenping Liu (102233), Ying Ping (5049203), Danhua Wang (504538), Gong Zhang (69122), Yiwen Sang (11750258), Xuchu Wang (668208), Zhihua Tao (236331)
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, extracellular vesicle, EpCAM, chemiluminescent immunoassay, prostate cancer, multivariate diagnostic model
-
3
المؤلفون: Qun Li (222962), Xiaoyan Zhang (50085), Jiao Feng (1463692), Dezhi Cheng (3916607), Lin Cai (104109), Zhang’an Dai (10583348), Shuyu Zhao (4453504), Jianmin Li (505211), Jingjing Huang (170112), Yu Fang (219603), Honglin Zhu (169482), Danhua Wang (504538), Sizhen Wang (10104212), Tonghui Ma (549091), Xianghe Lu (10583351)
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, next-generation sequencing, undifferential thyroid cancer, TERT promoter mutation, RET fusion, anlotinib, tumor origin